Diagnostics & Research Industry | Healthcare Sector | Mr. Francois Michelon CEO | NASDAQ (CM) Exchange | US29273B1044 ISIN |
US Country | 21 Employees | - Last Dividend | 9 Dec 2022 Last Split | 9 May 2017 IPO Date |
ENDRA Life Sciences Inc. is a pioneering company focused on enhancing the capabilities of clinical diagnostic ultrasound through advanced technology. Based in Ann Arbor, Michigan, and incorporated in 2007, ENDRA Life Sciences strives to revolutionize the way diseases are diagnosed and treated, with a special focus on nonalcoholic fatty liver disease. The company has made significant strides in the field through its collaboration with General Electric Company, showcasing its commitment to integrating cutting-edge research and development into practical medical applications.
ENDRA Life Sciences Inc. offers a range of innovative diagnostic imaging technologies aimed at improving patient care through more accurate and non-invasive diagnostics. These technologies include: